This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page A65-A65, February 1, 2025. Stroke-dizziness diagnosed in the ED is typically due to cerebellar or brainstem lesions which might only have subtle signs of central vestibular dysfunction. Stroke after the ED visit is infrequent but could have been missed at the index visit. cm (IQR, 1.1-4.0);
Stroke, Ahead of Print. We sought to explore the relationship between ART and stroke risk using population-level data.Methods:We conducted a retrospective cohort study using data from the National Inpatient Sample (NIS) registry from 2015-2020, including all delivery hospitalizations for patients aged 15-55 years. 100,000 vs. 9.1/100,000),
Stroke, Volume 56, Issue Suppl_1 , Page AWP82-AWP82, February 1, 2025. Background:ICH accounts for 10% of all strokes and is deadliest and most disabling stroke subtype. Patients with anticoagulant-related hemorrhage require rapid reversal to mitigate risk of hematoma expansion.
Stroke, Ahead of Print. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain. Eligible studies were phase 2 or 3 trials that tested therapeutic interventions within 1 month of stroke onset.
Stroke, Volume 55, Issue Suppl_1 , Page AWP41-AWP41, February 1, 2024. Background:Intracerebral Hemorrhage (ICH) accounts for 10% of strokes and has higher risk for mortality and disability. Findings: From 2020-2022 there were n=6,648 ICH patients entered, of that 49.1% Hematoma expansion may occur in ICH.
Stroke, Volume 56, Issue Suppl_1 , Page ATP3-ATP3, February 1, 2025. Introduction:Thrombolysis is the gold standard of treatment for acute ischemic stroke, but it must be administered within a narrow time window. Consecutive patients admitted between June 1, 2020, and June 30, 2023, were screened for inclusion in the study.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP26-AWMP26, February 1, 2025. Introduction:Several pre-hospital scales predict ischemic stroke due to large vessel occlusion; however, these scales often fail to detect atypical endovascular thrombectomy (EVT) cases, including posterior circulation and distal vessel occlusion.
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDAneurysmal subarachnoid hemorrhage (aSAH) is a major source of morbidity and mortality, and its management has undergone foundational changes over thepast 2 decades. The proportion treated by microsurgery fell from 70% to 23% in favor of endovascular surgery.
Stroke, Volume 55, Issue Suppl_1 , Page A58-A58, February 1, 2024. We fit segmented logistic regression models to evaluate the differences in the rates of in-hospital mortality between the pre-pandemic (January 2016-February 2020) and pandemic periods (March 2020-December 2020).
Stroke, Volume 56, Issue Suppl_1 , Page AWP155-AWP155, February 1, 2025. Background:Cancer-related stroke (CRS) is a rare condition where a tumor or its metastasis can compress a blood vessel and result in stroke. Patients were divided into those with strokes (ischemic or hemorrhagic) and those without strokes.
BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagicstroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods
Stroke, Volume 56, Issue Suppl_1 , Page ATP8-ATP8, February 1, 2025. Introduction:Treatment of acute stroke has its clear rules and established standards. The neurological deficit corresponded to 5 points in the median NIHSS after a previous stroke, 11 points at the time of recurrence, and 7 points after rescue therapy.
Stroke, Volume 56, Issue Suppl_1 , Page AWP225-AWP225, February 1, 2025. Background:Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are the standard of care for select stroke patients with acute large vessel occlusion (LVO). All patients consented to enrollment.Results:Forty-one patients were enrolled. were black.
Stroke, Volume 55, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2024. Background:Studies describing outcomes of subarachnoid hemorrhage (SAH) in children are sparse. 1.02], p<0.001), higher NIS-Subarachnoid Hemorrhage Severity Score (NIS-SSS) (12.64 [4.21-37.95], The median age was 11.8 years (95% CI, 11.0-12.5),
Stroke, Volume 55, Issue Suppl_1 , Page AWMP33-AWMP33, February 1, 2024. Background:The 2022 guidelines from the American Heart Association/American Stroke Association underscore the significance of coordinated multidisciplinary care and early discharge planning for spontaneous intracerebral hemorrhage (ICH) patients.
Stroke, Volume 55, Issue Suppl_1 , Page ATP171-ATP171, February 1, 2024. Introduction:Intracerebral hemorrhage (ICH) incidence follows both seasonal and diurnal patterns noted in the literature. hospitals between 1/1/2020 and 12/31/2021. of these scans had volumes above 30 ml.
Stroke, Volume 56, Issue Suppl_1 , Page A21-A21, February 1, 2025. Introduction:For stroke survivors, blood pressure (BP) reduction significantly lowers the risk of recurrence; a 10mmHg decrease in systolic BP is associated with a 20% risk reduction. Ischemic strokes accounted for 83.2% In TriNetX [n= 495,474; mean age 69, 17.7%
Stroke, Volume 56, Issue Suppl_1 , Page ATP203-ATP203, February 1, 2025. Introduction:Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, has been shown to reduce perihematomal edema in patients with acute intracerebral hemorrhage (ICH), but its effect on outcome was largely unclear. 2015 and Dec. 2015 and Dec.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP40-AWMP40, February 1, 2025. Introduction:Rehabilitation is essential to stroke recovery; however, access to rehabilitation varies in the US. We report recent national utilization rates of different rehabilitation disciplines in stroke survivors covered by different payors in the US.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOptimal triage strategies for patients suspected of acute ischemic stroke due to large vessel occlusion remains debated. Outcomes were compared for EVT hospitalizations with direct vs transferred presentation at discharge.
Stroke, Volume 55, Issue Suppl_1 , Page A11-A11, February 1, 2024. We sought to explore the relationship between ART and stroke risk using population-level data.Methods:We conducted a retrospective cohort study using data from the National Inpatient Sample (NIS) registry from 2015-2020. per 100,000), and any stroke (19.8
Stroke, Volume 56, Issue Suppl_1 , Page ATMP2-ATMP2, February 1, 2025. Introduction:Flow diversion (FD) is a minimally invasive treatment for unruptured intracranial aneurysms (UIA) and is often preferred over open cerebrovascular surgery; however, FD patients are at risk of post-procedural stroke and hemorrhage.
Stroke, Volume 56, Issue Suppl_1 , Page ATP70-ATP70, February 1, 2025. Introduction:A significant proportion of stroke patients are lost to follow up (LTFU) after discharge, which may be associated with increased risk of morbidity, mortality, and unnecessary hospitalization. vs. 47.4%); have an intracerebral (12.1% vs. 40.7%).
Stroke, Volume 55, Issue Suppl_1 , Page ATP158-ATP158, February 1, 2024. Introduction:Viscoelastic hemostatic assays can detect coagulopathy relevant for intracerebral hemorrhage (ICH) patients at risk for hematoma expansion. However, it is unclear whether these assays associate with long term ICH outcomes.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionTicagrelor use has become more prominent in acute ischemic stroke management in the presence of clopidogrel resistance(1‐2). A total of 162/433 (36.0%) had a presumed stroke etiology of intracranial atherosclerotic disease (ICAD).
Stroke, Volume 55, Issue Suppl_1 , Page AWP256-AWP256, February 1, 2024. Background:Assessing the economic impact of stroke and the potential for prevention through policy and programs raises questions about progress and underscores the importance of state-level data for targeted public health resource allocation. P<0.05
Stroke, Volume 56, Issue Suppl_1 , Page AWP72-AWP72, February 1, 2025. Background:Our system, comprised of 21 Northeast Ohio hospitals includes 3 Stroke Ready, 10 Primary and 1 Comprehensive Stroke Center (CSC). Clinical trials support the efficacy and safety of Tenecteplase for the treatment of acute ischemic stroke (AIS).
Stroke, Volume 55, Issue Suppl_1 , Page AWMP55-AWMP55, February 1, 2024. Introduction:There has been limited study of outcomes among surrogate decision makers who make decisions on life-sustaining treatments after severe stroke. Patient characteristics were mean age: 74.6, Female: 51.8%, Mean NIHSS: 14.7, deceased at 3 months: 53.1%.
Stroke, Ahead of Print. Background:Patients with severe stroke often rely on surrogate decision-makers for life-sustaining treatment decisions. Further study of outcomes among diverse populations of stroke surrogate decision-makers may help to identify sources of strength and resiliency that may be broadly applicable.
Stroke, Ahead of Print. Safety outcomes included symptomatic intracranial hemorrhage and 3-month mortality. Compared with alteplase, tirofiban was not associated with increased risk of symptomatic intracranial hemorrhage (6.8% Patients with acute intracranial large vessel occlusion within 4.5 versus 9.2%;P=0.51) versus 19.4%;P=0.76).
Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. 1.99]; aOR, 1.63 [95% CI, 1.14–2.32], 2.32], respectively).
Stroke, Volume 56, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2025. Final infarct segmentation included hemorrhagic transformation. Baseline demographics and National Institutes of Health Stroke Scale (NIHSS) were similar between groups. DWIR% = (DWIR/baseline DWI volume) 100 was calculated. P < 0.0001).
Stroke, Volume 55, Issue Suppl_1 , Page A157-A157, February 1, 2024. We also compared the safety of acute carotid stenting (CAS) in TLs with low ASPECTS.Methods:This prospective multicenter study from 16 centers included patients with anterior circulation TL from 2015-2020. 5.02; p=0.86), petechial hemorrhages (OR: 0.79, CI: 0.10-6.05;
Stroke, Volume 55, Issue Suppl_1 , Page AWP188-AWP188, February 1, 2024. Background:Endovascular therapy (EVT) has been reported to be safe and effective for acute ischemic stroke (AIS) patients with tandem lesions (TLs). However, the optimal anesthetic management during EVT for TL patients is unknown.
Stroke: Vascular and Interventional Neurology, Ahead of Print. Exploratory end points included neurologic deterioration, functional improvement, intracranial hemorrhage, and flow dynamics detected by transcranial Doppler ultrasonography. participants/month).
Stroke, Volume 55, Issue Suppl_1 , Page ATP5-ATP5, February 1, 2024. Data from 9 centers in the United States, Europe, and Asia for IA patients who undertook endovascular treatment (EVT) or microsurgical treatment (MST) between January 2016 and December 2020 were included for analysis. The primary outcome was 90-day mRS 0-2.
Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. were included from each dataset. were included from each dataset.
Stroke, Volume 56, Issue Suppl_1 , Page AWP177-AWP177, February 1, 2025. Introduction:Automated imaging analysis tools are increasingly used in clinical decision-making for stroke. mm slice; 3 mm spacing) series were collected from a retrospective database between February 2020 and May 2021.
Stroke, Volume 55, Issue Suppl_1 , Page AWP181-AWP181, February 1, 2024. Introduction:The management of wide-necked internal carotid artery (ICA) aneurysms is technically challenging with established endovascular and microsurgical techniques that are limited by the associated morbidity and/or recurrence. At a median 10.1 months (IQR: 6.3-12.6),
Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. We assessed the clinical characteristics and outcomes in an international cohort of patients with COVID-CVST.Methods:This was a registry study of consecutive COVID-CVST patients diagnosed between March 2020 and March 2023.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content